ArticleNature medicine2026

Cibisatamab and FAP-4-1BBL in microsatellite-stable colorectal cancer: a phase 1b trial.

Ignacio Melero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.